According to Bloomberg, the bill gives Federal Reserve regulators more flexibility in applying capital rules to big U.S. life insurers. Under the current provision, the Federal Reserve puts capital standard similar to those put on banks on insurers deemed "systemically important." MetLife is in the final stages of being designated systemically important.
The new bill would give the Federal Reserve the flexibility to change those regulations for the MetLife and Prudential (PRU), which is currently designated at systemically important.
Must read: Warren Buffett's 25 Favorite Stocks
TheStreet Ratings team rates METLIFE INC as a Buy with a ratings score of A-. TheStreet Ratings Team has this to say about their recommendation:
"We rate METLIFE INC (MET) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, increase in stock price during the past year, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow."